Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Melanoma 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Brain Neoplasms 1Adenocarcinoma 1

Interventions

AZD 6244 19trametinib 5Lovastatin 5Deoxycholic Acid 4mirdametinib 3Lasers, Solid-State 3pirfenidone 2fludarabine 2binimetinib 2Vincristine 2Vinblastine 2Transcranial Direct Current Stimulation 2Specimen Handling 2Sirolimus 2Polidocanol 2Magnetic Resonance Spectroscopy 2Magnetic Resonance Imaging 2Lasers 2Lamotrigine 2Inhalation 2Everolimus 2Carboplatin 2Blood Specimen Collection 2Biopsy 2Acetylcysteine 2tipifarnib 1thymoglobulin 1talimogene laherparepvec 1pomalidomide 1peginterferon alfa-2b 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibromatosis 1 × Acetaminophen × CNS × Clear all
NCT03649165 2018-11-08

A Study to Evaluate Bioavailability and Food Effect of Selumetinib (AZD6244) in Healthy Male Participants

AstraZeneca

Phase 1 Completed
24 enrolled
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡